Outlook Therapeutics, Inc. (NASDAQ:OTLK) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 17, 2026.
The Healthcare company reported Q0 revenue of .
Outlook Therapeutics, Inc.'s stock currently trades at $0.42 with a market capitalization of $89.3M.